Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.  Researchers at Walter and Eliza Hall Institute and Peter MacCallum Cancer Centre in Melbourne found that combining the immune-boosting drugs with chemotherapy increased survival in mice with a type of breast cancer. Although it’s too early to say whether this will work in people, study author Dr Daniel Gray said the results offer “compelling evidence” to test out the combination in clinical trials for women with this disease. “The study highlights a group of patients that are most likely to benefit from drugs boosting the immune system,” said Professor Aymen Al-Shamkhani, a Cancer Research UK expert on immunotherapy from the University of Southampton. 

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-06-08-combining-immunotherapies-could-benefit-some-aggressive-breast-cancers